Perampanel (Fycompa - Eisai Ltd.) indication: epilepsy, partial-onset seizures
CADTH
Record ID 32014000877
English
Authors' recommendations:
The Canadian Drug Expert Committee (CDEC) recommends that perampanel be listed as an adjunctive therapy in the management of partial-onset seizures in patients with epilepsy who are not satisfactorily controlled with conventional therapy, if the following clinical criteria and condition are met:
1.Patients are currently receiving two or more antiepileptic drugs (AEDs).
2. Less costly AEDs are ineffective or not appropriate.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/cdr/complete/cdr_complete_Fycompa_October-21-13_e.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Seizures
- Epilepsy
- Pyridones
- Nitriles
- Anticonvulsants
- Epilepsies, Partial
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.